Уноси

• Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs (2014-06)

  B. Godman, R. Malmstrom, E. Digene, S. Jayathissa, S. McTaggart, T. Cars, S. Alvarez-Madrazo, C. Baumgartel, A. Brzezinska, A. Bucsics, S. Campbell, I. Eriksson, A. Finlayson, J. Furst, K. Garuoliene, I. Gutierrez-Ibarluzea, K. Hviding, H. Herholz, R. Joppi, R. Joppi, M. Kalaba, O. Laius, K. Malinowska, H. Pedersen, V. Marković Peković, J. Piessnegger, G. Selke, C. Sermet, S. Spillane, D. Tomek, L. Vončina, V. Vlahović-Palčevski, J. Wale, M. Wladysiuk, M. van Woerkom, C. Zara, L. Gustafsson, Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs, Frontiers in Pharmacology, Vol. 5, pp. 1 - 11, Jun, 2014

• Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications (2014-06)

  B. Godman, B. Wettermark, M. van Woerkom, J. Fraeyman, S. Alvarez-Madrazo, C. Berg, I. Bishop, A. Bucsics, S. Campbell, A. Finlayson, J. Furst, K. Garuoliene, H. Herholz, M. Kalaba, O. Laius, J. Piessnegger, C. Sermet, U. Schwabe, V. Vlahović-Palčevski, V. Marković Peković, L. Vončina, K. Malinowska, C. Zara, L. Gustafsson, Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications, Frontiers in Pharmacology, Vol. 5, pp. 1 - 9, Jun, 2014